James Davidson, DO
Orthopaedic Surgery of the Spine · Clearwater, FLNPI 1770543704
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $205,645 of the $272,146 with a category attached, or 75.6%. The Institute Of Musculoskeletal Science And Education accounts for 73.3% of it on its own, with 21 other manufacturers making up the rest. 2025 is the largest year on record at $93,788, 3.6 times the $25,958 reported in 2019.
Across 149 payments — averaging $1826.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- The Institute Of Musculoskeletal Science And Education$200K
- Philadelphia Medical Management Company LLC$37K
- Camber Spine Technologies LLC$15K
- Surgalign Spine Technologies, Inc.$14K
- Premia Spine, Ltd.$3K
- Zimmer Biomet$2K
- plus $3K from 16 others
What the payments were for
- Royalty or licence$205,64576%
- Consulting fees$55,51720%
- Travel & lodging$5,6442%
- Food & beverage$5,3402%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| The Institute Of Musculoskeletal Science And Education | 35 | $199,590 |
| Philadelphia Medical Management Company LLC | 2 | $36,667 |
| Camber Spine Technologies LLC | 45 | $14,973 |
| Surgalign Spine Technologies, Inc. | 6 | $13,573 |
| Premia Spine, Ltd. | 1 | $2,500 |
| Zimmer Biomet | 18 | $1,724 |
| Boston Scientific | 9 | $1,064 |
| Relievant Medsystems, Inc. | 8 | $565 |
| 4web, Inc. | 4 | $295 |
| Globus Medical | 3 | $272 |
| Republic Spine | 1 | $244 |
| Amgen | 2 | $128 |
| Medtronic(2 entities) | 3 | $120 |
| Carlsmed, Inc. | 1 | $99 |
| Amplify Surgical, Inc. | 1 | $73 |
| Orthofix Medical, Inc. | 2 | $72 |
| Coastal Medical Technologies LLC | 1 | $55 |
| Vertex | 2 | $41 |
| Forte Bio-pharma LLC | 2 | $35 |
| Nevro Corp. | 1 | $27 |
| Si-bone, Inc. | 1 | $17 |
| Zyla Life Sciences, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$272,146 in reported general payments places this provider in the 80th percentile of 159 orthopaedic surgery of the spine providers in Florida.
See all orthopaedic surgery of the spine providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProliaDenosumab | 26 | $44,651 |
| Celecoxib | 23 | $1,007 |
| Methylprednisolone | 75 | $525 |
| Mupirocin | 35 | $218 |
| Oxycodone Hcl | 26 | $200 |
| Cyclobenzaprine Hcl | 27 | $154 |
| Gabapentin | 12 | $78 |
| Tramadol Hcl | 15 | $60 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenProlia | $128 | $44,65126 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 159 orthopaedic surgery of the spine providers in Florida.
Other orthopaedic surgery of the spine in Clearwater
- Michael VeneziaClearwater$201K
- Harry ShufflebargerMiami$3.5M
- Paul KellerMelbourne$3.4M
- Thomas SweeneySarasota$2.3M
- Geoffrey CronenTampa$2.2M
- James BillysOdessa$1.9M
- Mark DekutoskiDestin$1.8M
- Farhan SiddiqiOdessa$1.7M
- Samuel JosephSafety Harbor$1.7M
- Thomas ErricoMiami$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.